Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer

BACKGROUND: Ranpirnase (Rap) is an amphibian ribonuclease with reported antitumor activity, minimal toxicity, and negligible immunogenicity in clinical studies, but the unfavorable pharmacokinetics and suboptimal efficacy hampered its further clinical development. To improve the potential of Rap-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Donglin, Cardillo, Thomas M, Wang, Yang, Rossi, Edmund A, Goldenberg, David M, Chang, Chien-Hsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015355/
https://www.ncbi.nlm.nih.gov/pubmed/24606732
http://dx.doi.org/10.1186/1476-4598-13-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015355/
https://www.ncbi.nlm.nih.gov/pubmed/24606732
http://dx.doi.org/10.1186/1476-4598-13-53

Ejemplares similares